BFRG: Bullfrog AI Holdings, Inc. Stock

by  •  • Comments Off on BFRG: Bullfrog AI Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 22.77
Enterprise Value ($M) 20.36
Book Value ($M) 2.59
Book Value / Share 0.33
Price / Book 8.78
NCAV ($M) 2.59
NCAV / Share 0.33
Price / NCAV 8.80

Profitability (mra)
Return on Invested Capital (ROIC) -1.91
Return on Assets (ROA) -0.86
Return on Equity (ROE) -1.16

Liquidity (mrq)
Quick Ratio 15.03
Current Ratio 15.03

Balance Sheet (mrq) ($M)
Current Assets 2.77
Assets 2.78
Liabilities 0.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.07
Operating Income -5.37
Net Income -5.36

Cash Flow Statement (mra) ($M)
Cash From Operations -6.00
Cash from Investing 0.00
Cash from Financing 8.57

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 ☐ TRANSITION REPORT PURSU
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-04-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2022 ☐ TRANSITION REPORT UNDER SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-23 13,405 48,031 27.91
2024-04-22 6,682 7,499 89.11
2024-04-19 19,171 20,235 94.74
2024-04-18 23,402 18,154 128.91

(click for more detail)

Similar Companies
BCDA – BioCardia, Inc. BCLI – Brainstorm Cell Therapeutics Inc.
BCTX – BriaCell Therapeutics Corp. BFRI – Biofrontera Inc.
BGXX – Bright Green Corporation


Financial data and stock pages provided by
Fintel.io